Citations (42)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Claudio Annaloro, Lorena Airaghi, Giorgia Saporiti, Francesco Onida, Agostino Cortelezzi & Giorgio Lambertenghi Deliliers. (2012) Metabolic syndrome in patients with hematological diseases. Expert Review of Hematology 5:4, pages 439-458.
Read now
Read now
Nikolaos Papanas, Efstratios Maltezos & Dimitri P Mikhailidis. (2010) Metformin and cancer: licence to heal?. Expert Opinion on Investigational Drugs 19:8, pages 913-917.
Read now
Read now
Articles from other publishers (40)
Md Sumon Sarkar, Md Misor Mia, Md Al Amin, Md Sojib Hossain & Md Zahidul Islam. (2023) Bioinformatics and network biology approach to identifying type 2 diabetes genes and pathways that influence the progression of breast cancer. Heliyon, pages e16151.
Crossref
Crossref
Martyna Bednarczyk, Małgorzata Muc-Wierzgoń, Sylwia Dzięgielewska-Gęsiak, Edyta Fatyga & Dariusz Waniczek. (2023) Transcription of Autophagy Associated Gene Expression as Possible Predictors of a Colorectal Cancer Prognosis. Biomedicines 11:2, pages 418.
Crossref
Crossref
Shuwen Dong, Zheng Wang, Kunwei Shen & Xiaosong Chen. (2021) Metabolic Syndrome and Breast Cancer: Prevalence, Treatment Response, and Prognosis. Frontiers in Oncology 11.
Crossref
Crossref
Yen-Yun Wang, Amos C. Hung, Steven Lo & Shyng-Shiou F. Yuan. (2021) Adipocytokines visfatin and resistin in breast cancer: Clinical relevance, biological mechanisms, and therapeutic potential. Cancer Letters 498, pages 229-239.
Crossref
Crossref
Ana M. Barbosa & Fátima Martel. (2020) Targeting Glucose Transporters for Breast Cancer Therapy: The Effect of Natural and Synthetic Compounds. Cancers 12:1, pages 154.
Crossref
Crossref
J. Faria, G. Negalha, A. Azevedo & F. Martel. (2019) Metformin and Breast Cancer: Molecular Targets. Journal of Mammary Gland Biology and Neoplasia 24:2, pages 111-123.
Crossref
Crossref
Clinton Yam, Francisco J. Esteva, Miral M. Patel, Akshara S. Raghavendra, Naoto T. Ueno, Stacy L. Moulder, Kenneth R. Hess, Girish S. Shroff, Silvia Hodge, Kimberly H. Koenig, Mariana Chavez Mac Gregor, Robin L. Griner, Sai-Ching J. Yeung, Gabriel N. Hortobagyi & Vicente Valero. (2019) Efficacy and safety of the combination of metformin, everolimus and exemestane in overweight and obese postmenopausal patients with metastatic, hormone receptor-positive, HER2-negative breast cancer: a phase II study. Investigational New Drugs 37:2, pages 345-351.
Crossref
Crossref
Yun-Cheol Chae, Ji-Young Kim, Jin Woo Park, Kee-Beom Kim, Hyein Oh, Kyung-Hwa Lee & Sang-Beom Seo. (2019) FOXO1 degradation via G9a-mediated methylation promotes cell proliferation in colon cancer. Nucleic Acids Research 47:4, pages 1692-1705.
Crossref
Crossref
Mohsin HK Roshan, Yan K Shing & Nikolai P Pace. (2019) Metformin as an adjuvant in breast cancer treatment. SAGE Open Medicine 7, pages 205031211986511.
Crossref
Crossref
Prateek Sharma & Sanjeev Kumar. (2018) Metformin inhibits human breast cancer cell growth by promoting apoptosis via a ROS-independent pathway involving mitochondrial dysfunction: pivotal role of superoxide dismutase (SOD). Cellular Oncology 41:6, pages 637-650.
Crossref
Crossref
Tuğba Adak, Afshin Samadi, Ayşe Zeynep Ünal & Suna Sabuncuoğlu. (2018) A reappraisal on metformin. Regulatory Toxicology and Pharmacology 92, pages 324-332.
Crossref
Crossref
Leslie H. Clark & Victoria L. Bae-Jump. 2018. Focus on Gynecologic Malignancies. Focus on Gynecologic Malignancies
279
304
.
Jianjun Han, Weiya Z. Wysham, Yan Zhong, Hui Guo, Lu Zhang, Kim M. Malloy, Hallum K. Dickens, Gene Huh, Douglas Lee, Liza Makowski, Chunxiao Zhou & Victoria L. Bae-Jump. (2017)
Increased efficacy of metformin corresponds to differential metabolic effects in the ovarian tumors from obese
versus
lean mice
. Oncotarget 8:67, pages 110965-110982.
Crossref
Crossref
Tian Li, Xiangzhou Sun & Xianhan Jiang. (2017) UCA1 involved in the metformin-regulated bladder cancer cell proliferation and glycolysis. Tumor Biology 39:6, pages 101042831771082.
Crossref
Crossref
Ui-Jin Bae, Mi-Ra Oh, Tae-Sung Jung, Soo-Wan Chae & Byung-Hyun Park. (2017) Decursin and decursinol angelate-rich Angelica gigas Nakai extract suppresses de novo lipogenesis and alleviates nonalcoholic fatty liver disease and dyslipidemia in mice fed a high fat diet. Journal of Functional Foods 31, pages 208-216.
Crossref
Crossref
Osama A. Arshad, Priyadharshini S. Venkatasubramani, Aniruddha Datta & Jijayanagaram Venkatraj. (2016) Using Boolean Logic Modeling of Gene Regulatory Networks to Exploit the Links Between Cancer and Metabolism for Therapeutic Purposes. IEEE Journal of Biomedical and Health Informatics 20:1, pages 399-407.
Crossref
Crossref
Jin KimYoon Hee LeeJung Han Yoon ParkMi-Kyung Sung. (2015) Estrogen deprivation and excess energy supply accelerate 7,12-dimethylbenz(a)anthracene-induced mammary tumor growth in C3H/HeN mice. Nutrition Research and Practice 9:6, pages 628.
Crossref
Crossref
Tao Zhang, Xinyang Wang, Dalin He, Xunbo Jin & Peng Guo. (2014) Metformin sensitizes human bladder cancer cells to TRAIL-induced apoptosis through mTOR/S6K1-mediated downregulation of c-FLIP. Anti-Cancer Drugs 25:8, pages 887-897.
Crossref
Crossref
Ruchi Bhandari, George A. Kelley, Tara A. Hartley & Ian R. H. Rockett. (2014) Metabolic Syndrome Is Associated with Increased Breast Cancer Risk: A Systematic Review with Meta-Analysis. International Journal of Breast Cancer 2014, pages 1-13.
Crossref
Crossref
Stephen D. Hursting. 2014. Advances in Nutrition and Cancer. Advances in Nutrition and Cancer
21
33
.
Sarah S. Cohen & Loren Lipworth. 2014. Impact of Energy Balance on Cancer Disparities. Impact of Energy Balance on Cancer Disparities
201
232
.
Tao Zhang, Peng Guo, Yinan Zhang, Hui Xiong, Xiao Yu, Shan Xu, Xinyang Wang, Dalin He & Xunbo Jin. (2013) The Antidiabetic Drug Metformin Inhibits the Proliferation of Bladder Cancer Cells in Vitro and in Vivo. International Journal of Molecular Sciences 14:12, pages 24603-24618.
Crossref
Crossref
Ai Kubo, Michael Blaise Cook, Nicholas J Shaheen, Thomas L Vaughan, David C Whiteman, Liam Murray & Douglas A Corley. (2013) Sex-specific associations between body mass index, waist circumference and the risk of Barrett's oesophagus: a pooled analysis from the international BEACON consortium. Gut 62:12, pages 1684-1691.
Crossref
Crossref
Vladimir N. Anisimov & Andrzej Bartke. (2013) The key role of growth hormone–insulin–IGF-1 signaling in aging and cancer. Critical Reviews in Oncology/Hematology 87:3, pages 201-223.
Crossref
Crossref
Jiezhong Chen, Mengna Chi, Chen Chen & Xu Dong Zhang. (2013) Obesity and melanoma: Exploring molecular links. Journal of Cellular Biochemistry 114:9, pages 1955-1961.
Crossref
Crossref
Jen‐Chung Ko, Yu‐Ching Huang, Huang‐Jen Chen, Sheng‐Chieh Tseng, Hsien‐Chun Chiu, Ting‐Yu Wo, Yi‐Jhen Huang, Shao‐Hsing Weng, Robin Y. Y. Chiou & Yun‐Wei Lin. (2013) Metformin Induces Cytotoxicity by Down‐Regulating Thymidine Phosphorylase and Excision Repair Cross‐Complementation 1 Expression in Non‐Small Cell Lung Cancer Cells. Basic & Clinical Pharmacology & Toxicology 113:1, pages 56-65.
Crossref
Crossref
Emmanuel Beck & André J. Scheen. (2013) Quels bénéfices antitumoraux attendre de la metformine ?. Annales d'Endocrinologie 74:2, pages 137-147.
Crossref
Crossref
Christos V. Rizos & Moses S. Elisaf. (2013) Metformin and cancer. European Journal of Pharmacology 705:1-3, pages 96-108.
Crossref
Crossref
Jorge Eduardo Duque, Juliana Velez, Ismael Samudio & Enoch Lai. (2012) Metformin as a Novel Component of Metronomic Chemotherapeutic Use: A Hypothesis. Journal of Experimental & Clinical Medicine 4:3, pages 140-144.
Crossref
Crossref
Rabbie K. Hanna, Chunxiao Zhou, Kimberly M. Malloy, Li Sun, Yan Zhong, Paola A. Gehrig & Victoria L. Bae-Jump. (2012) Metformin potentiates the effects of paclitaxel in endometrial cancer cells through inhibition of cell proliferation and modulation of the mTOR pathway. Gynecologic Oncology 125:2, pages 458-469.
Crossref
Crossref
A V Lavrenko, N L Kutsenko, L A Kutsenko, T V Mamontova & I P Kaĭdashev. (2012) The action of metformin on the production of pro-inflammatory cytokines and insulin resistance (NF-kB signal pathway). Problems of Endocrinology 58:2, pages 25-28.
Crossref
Crossref
Spike D. L. Postnikoff, Mackenzie E. Malo, Berchman Wong & Troy A. A. Harkness. (2012) The Yeast Forkhead Transcription Factors Fkh1 and Fkh2 Regulate Lifespan and Stress Response Together with the Anaphase-Promoting Complex. PLoS Genetics 8:3, pages e1002583.
Crossref
Crossref
Abayomi O AkanjiRobert J Smith. (2012) The Insulin-Like Growth Factor System, Metabolic Syndrome, and Cardiovascular Disease Risk. Metabolic Syndrome and Related Disorders 10:1, pages 3-13.
Crossref
Crossref
Alvaro Luis Ronco & Eduardo De StéfaniAlvaro Luis Ronco & Eduardo De Stéfani. 2012. Nutritional Epidemiology of Breast Cancer. Nutritional Epidemiology of Breast Cancer
99
108
.
Rosalyn D. Ferguson & Derek LeRoith. 2012. Insulin-like Growth Factors and Cancer. Insulin-like Growth Factors and Cancer
37
72
.
Mario I. Ortiz. (2011) Blockade of the antinociception induced by diclofenac, but not of indomethacin, by sulfonylureas and biguanides. Pharmacology Biochemistry and Behavior 99:1, pages 1-6.
Crossref
Crossref
Jesús Pérez-Losada, Andrés Castellanos-Martín & Jian-Hua Mao. (2011) Cancer evolution and individual susceptibility. Integrative Biology 3:4, pages 316.
Crossref
Crossref
Pamela J. Goodwin. (2010) Metabolic Syndrome, Insulin Resistance, and Inflammation in Breast Cancer: Impact on Prognosis and Adjuvant Interventions. Current Breast Cancer Reports 2:4, pages 182-189.
Crossref
Crossref
Vladimir N. Anisimov. (2010) Metformin for aging and cancer prevention. Aging 2:11, pages 760-774.
Crossref
Crossref
Pamela J. Goodwin. (2010) Commentary on: “Effect of obesity on survival in women with breast cancer: systematic review and meta-analysis” (Melinda Protani, Michael Coory, Jennifer H. Martin). Breast Cancer Research and Treatment 123:3, pages 637-640.
Crossref
Crossref